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Available online 29 January 2016Phosphoglycerate mutase family member 5 (PGAM5) is a mitochondrial protein phosphatase that has been
reported to be involved in various stress responses from mitochondrial quality control to cell death. However,
its roles in vivo are largely unknown. Here, we show that Pgam5-deﬁcient mice are resistant to several metabolic
insults. Under cold stress combinedwith fasting, Pgam5-deﬁcientmice bettermaintainedbody temperature than
wild-type mice and showed an extended survival rate. Serum triglycerides and lipid content in brown adipose
tissue (BAT), a center of adaptive thermogenesis, were severely reduced in Pgam5-deﬁcient mice. Moreover,
although Pgam5 deﬁciency failed to maintain proper mitochondrial integrity in BAT, it reciprocally resulted in
the dramatic induction of ﬁbroblast growth factor 21 (FGF21) that activates various functions of BAT including
thermogenesis. Thus, the enhancement of lipid metabolism and FGF21 may contribute to the cold resistance of
Pgam5-deﬁcient mice under fasting condition. Finally, we also found that Pgam5-deﬁcient mice are resistant
to high-fat-diet-induced obesity. Our study uncovered that PGAM5 is involved in the whole-body metabolism
in response to stresses that impose metabolic challenges on mitochondria.
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FGF211. Introduction
Phosphoglycerate mutase family member 5 (PGAM5) is a
mitochondria-resident protein that belongs to the PGAM family, an
evolutionarily conserved enzyme family. Prototypical PGAM family
member proteins function in glycolysis as mutases (Jedrzejas, 2000).
Although the amino acid sequence of the catalytic core of other PGAM
family members is conserved in PGAM5, we previously reported that
PGAM5 lacks mutase activity and instead acts as a Ser/Thr-speciﬁc
protein phosphatase (Takeda et al., 2009). Although a previous re-
port suggested that PGAM5 is targeted to the outer mitochondrial
membrane (OMM) (Lo and Hannink, 2008), we found that PGAM5
is mainly localized to the inner mitochondrial membrane (IMM)
through its N-terminal transmembrane domain and is cleaved by
presenilins-associated rhomboid-like protein (PARL), an IMM-
resident intramembrane protease, in response to the loss of mito-
chondrial membrane potential (Sekine et al., 2012). Recently, it has. This is an open access article underbeen suggested that PGAM5 is involved in several stress responses
at both the cellular and organelle levels, including apoptosis
(Zhuang et al., 2013), necroptosis (Wang et al., 2012), and autopha-
gic mitochondrial degradation (Chen et al., 2014; Lu et al., 2014).
However, the physiological roles of PGAM5 in vivo are largely un-
known, except for one report suggesting that Pgam5-deﬁcient mice
show late-onset Parkinson's disease-like phenotypes (Lu et al.,
2014).
Mitochondria, inwhich PGAM5 resides, are the largest cellular ener-
gy store, housing OXPHOS proteins for ATP generation and β-oxidation
enzymes for fuel delivery.When bodies are exposed to stresses that dis-
rupt energy homeostasis, it is expected that several metabolic chal-
lenges are imposed on mitochondria. Among such metabolic stresses,
mitochondria play important roles in cold resistance. Cold stress sympa-
thetically activates brown adipose tissue (BAT), a center of heat produc-
tion (Morrison et al., 2014). Heat generation in BAT requires the IMM-
resident uncoupler UCP1, which dissipates chemical energy to heat,
and this process is termed nonshivering adaptive thermogenesis
(Krauss et al., 2005). Activated BAT burns lipids through β-oxidation
to sustain heat production, which results in an increase in energy ex-
penditure (Townsend and Tseng, 2014). In addition to UCP1, the abla-
tion of components that are required for β-oxidation, such as carnitinethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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83S. Sekine et al. / EBioMedicine 5 (2016) 82–92palmitoyl-transferase 1β (CPT1β) and acyl-CoA synthetase long-chain
family member 1 (ACSL1), all of which are vulnerable to cold stress
(Ellis et al., 2010; Enerback et al., 1997; Ji et al., 2008), emphasizes the
importance of mitochondria for cold resistance. Several humoral factors
also participate in the activation of BAT (Villarroya and Vidal-Puig,
2013). Among these factors, FGF21, the 21st member of the ﬁbroblast
growth factor (FGF) family (Nishimura et al., 2000), is induced by cold
stress (Chartoumpekis et al., 2011;Hondares et al., 2011) andultimately
protectsmice fromcold (Fisher et al., 2012). Interestingly, several recent
reports have suggested that FGF21 is also induced in response to mito-
chondrial dysfunction (Dogan et al., 2014; Kim et al., 2013a,b), raising
the possibility that FGF21 can regulate whole-body energy expenditure
when enormous metabolic challenges are imposed on mitochondria.
Here, we revealed that Pgam5 knockout (KO) mice are resistant to
cold stress combined with fasting. Consistent with the knowledge that
cold sensitivity is correlated with obese phenotype (Lin and Li, 2004),
Pgam5 KO mice also showed a resistance against high-fat-diet-induced
obesity. Our study uncovered thatmitochondria-resident stress respon-
sive molecule PGAM5 may act as a metabolic regulator in vivo.
2. Materials and Methods
2.1. Mice
Themicewere housed in a speciﬁc pathogen-free facility. For fasting
and cold stress, 9–11-week-oldmalemice were fasted for 12 h and sub-
sequently kept in a cold room (4 °C) for the indicated time periods. For
the HFD-induced obesity model, 4–5-week-old male mice were fed a
HFD (High Fat Diet 32, CLEA Japan, Inc.) for the indicated time periods.
Body temperature was measured using a BAT-12 (MUROMACHI KIKA
I). All of the mouse experiments were performed in accordance with
protocols approved by the Animal Research Committee of the Graduate
School of Pharmaceutical Sciences at the University of Tokyo (Tokyo,
Japan).
2.2. Generation of Pgam5 KO Mice
A targeting vectorwas constructed inwhich a 4.9-kb fragment of the
Pgam5 gene, containing exons 1–5,was replaced by a reversed-oriented
neomycin phosphotransferase cassette. An upstream 6.3-kb fragment
and a downstream3.9-kb fragment of this cassette were used as homol-
ogous arms for recombination (Figure S1a). A Not I-linearized targeting
vector was electroporated into RENKA embryonic stem cells (Transgen-
ic Inc., Japan) derived from C57BL/6 mice and subjected to selection
with G418. After the disruption of the Pgam5 gene was conﬁrmed by
Southern blotting, established ES cells were injected into 8-cell-stage
embryos of ICR mice. The germline transmission of the mutated allele
to F1 mice, as obtained by an intercross of resulting male chimeras
and female C57BL/6 mice, was conﬁrmed by Southern blotting
(Figure S1b). Homozygous mutant mice were obtained by F1 heterozy-
gous intercrosses. Mice were housed in speciﬁc pathogen-free facilities.
Mouse genotyping was performed by PCR using the following oligonu-
cleotide primers:
Forward primer for wild allele: 5′-CTGCCTTCAGGAACTACATCCA
CCG-3′;
Forward primer for mutant allele: 5′-TTAAGGGCCAGCTCATTCCTCC
CAC-3′;
Reverse primer: 5′-ACTTCTCTGACCAGGCTTCACCAGC-3′.
2.3. Cell Culture
The methods for the primary culture of mouse skin ﬁbroblasts
(MSFs), mouse embryonic ﬁbroblasts (MEFs) and bone-marrow-
derived macrophages (BMDMs) were described previously (Iriyama
et al., 2009; Tobiume et al., 2001).2.4. Blood Chemistry
Measurements of serum TG and FFA were performed by SRL, Inc.
Serum FGF21 levels were determined using an ELISA kit (R&D).
2.5. Histology
Tissues were ﬁxed in 4% paraformaldehyde to make parafﬁn-
embedded blocks. Each section (10 μm) was stained with hematoxylin
and eosin.
2.6. Glucose and Insulin Tolerance Test
GTTwas performed in 12-h-fastedmice by the intraperitoneal injec-
tion of glucose (1 g/kg B.W.). ITT was performed in 4-h-fasted mice by
an intraperitoneal injection of insulin (0.75 U/kg B.W.). Blood glucose
concentrations were measured with a Medi-safe mini GR-102
(TERUMO).
2.7. Quantiﬁcation of mRNA Expression
Total RNA was isolated from tissues using the Isogen reagent
(Wako) and reverse transcribed using the QuantiTect Reverse Tran-
scription Kit (Qiagen). PCR was performed using the Power SYBR
Green PCR Master Mix (Roche) and LightCycler® (Roche). All expres-
sion levels were normalized to that of S18 mRNA.
Real-time RT-PCR primers used (5′ to 3′):Forward Reverse36 ttgtacctatactgtggctaaatgaga cttgtgttttgaacatttctgctt
dea aaaccatgaccgaagtagcc aggccagttgtgatgactaagac
t1a gctgtcaaagataccgtgagc tctccctccttcatcagtgg
ovl3 gaggcctctcatcctctggt ttgccataaacttccacatcc
t1b gcccatgtgctcctacca ctctgagaggtgctgtagcaag
io2 ctgcgctgtgtctggaac ggagcatcttcacccagttt
f21 cacaccgcagtccagaaag tgacacccaggatttgaatg
pe (HSL) agcgctggaggagtgtttt ccgctctccagttgaacc
npla2 (ATGL) tgaccatctgccttccaga tgtaggtggcgcaagaca
c27a1 (FATP1) gacaagctggatcaggcaag gaggccacagaggctgttc
c27a3 (FATP3) gagaacttgccaccgtatgc ggtctcagtagtggccaaaga
c27a4 (FATP4) ggcagtgagatggcctca cagagcagaagaggctgagtg
8 tccagcacattttgcgagta cagtgatggcgaaggctatt
cp1 gatgtggtaaaaacaagattcatca cgcagaaaagaagccacaau2.8. Immunoblot Analysis
Tissues were lysed with IP lysis buffer (20 mM Tris–HCl, pH 7.5,
150 mM NaCl, 10 mM EDTA, pH 7.5, 1% Na-deoxycholate, 1% Triton X-
100) with protease inhibitors (1 mM phenylmethylsulfonyl ﬂuoride,
5 mg/mL leupeptin) and a 25× phosphatase inhibitor cocktail
(200 mM NaF, 300 mM beta-glycerophosphate, 25 mM Na3VO4,
30 mM Na2MoO4, 50 mM Imidazole). The lysates were resolved by
SDS-PAGE and electroblotted onto polyvinylidene diﬂuoride mem-
branes. After blocking with 5% skim milk in TBS-T (50 mM Tris–HCl,
pH 8.0,
150 mM NaCl and 0.05% Tween 20), the membranes were probed
with antibodies. The antibody/antigen complexes were detected using
the ECL system (GE Healthcare).
2.9. The Measurement of VLDL Release From Liver
Fasted mice were intravenously injected with 100 μl/20 g body
weight 10% Triton WR-1339 (Santa Cruz) in PBS and subsequently ex-
posed to cold. After 4 h, serum was collected, and TG measurements
were performed by SRL, Inc.
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Fasted mice were intraperitoneally injected with 2.5 mg/kg body
weight ISRIB (Sigma) in buffer (12.5% DMSO, 12.5% PEG400, 75% PBS)
and subsequently exposed to cold. After 5 h, BAT was dissected and
subjected to subsequent analyses.
2.11. Indirect Calorimetry
Whole-body O2 consumption was measured using an open-
circuit four-chamber indirect calorimetry system (Muromachi).
Mice had ad libitum access to food andwater, and data were recorded
for a 24-h period with light from 7:00 to 19:00.
2.12. Electron Microscopic Analysis
For electron microscopy, the brown adipose tissues were quickly
removed from the mice that had been deeply anesthetized and ﬁxed
by cardiac perfusion with 2% paraformaldehyde-2% glutaraldehyde
buffered with 0.1 mol/L phosphate buffer, were post-ﬁxed with 2%
OsO4, dehydrated with a graded series of alcohol, and embedded in
Epon 812. Ultrathin sections were cut with an ultramicrotome
(UC6; Leica Microsystems, Vienna, Austria), stained with uranyl ace-
tate and lead citrate, and observed with a Hitachi HT7700 electron
microscope (Hitachi, Tokyo, Japan). The mean gray scale value of
each mitochondrion was measured using Image J. Approximately
150 mitochondria from 8–9 images for each mouse and approxi-
mately 450 mitochondria in total for each genotype were analyzed
(n = 3).
2.13. Antibodies
For immunoblot analysis, the following primary antibodies were
used: α-tubulin (Santa Cruz), UCP1 (Abcam), FGF21 (Santa Cruz),
phospho-eif2α (Cell Signaling) and eif2α (Santa Cruz). The generation
of the rabbit polyclonal anti-PGAM5 antibody (RTL) was described
previously (Takeda et al., 2009).
3. Results
3.1. Pgam5 Knockout (KO) Mice Exhibit a Resistance Phenotype Against
Cold Stress Under Fasting Condition
To address the in vivo functions of PGAM5 in mammals, we
engineered a targeting vector to generate whole-body Pgam5 knockout
(KO) mice (Figure S1a). Homozygosity for the mutation was conﬁrmed
by Southern blot and PCR analyses (Figure S1b), and a complete ablation
of PGAM5 protein was also conﬁrmed by immunoblot analysis using
several primary cell lines that were derived from the generated
Pgam5 KO mice (Figure S1c). Pgam5 KO mice were viable and devel-
oped normally with no obvious phenotypes, at least during the early
stage of life.
Previous studies by us and others have speculated that PGAM5 is
a mitochondria-resident stress-responsive molecule (Chen et al.,
2014; Lu et al., 2014; Sekine et al., 2012; Wang et al., 2012; Zhuang
et al., 2013). Hence, we examined the phenotypes of Pgam5 KO
mice under cold exposure as one of the in vivomodels that might im-
pose stresses on mitochondria in vivo. We tested a metabolically se-
vere cold-stress model. In this model, mice are ﬁrst kept under fasted
conditions and are subsequently subjected to cold exposure (Fig. 1a,
left panel). As a result, we found that the ablation of Pgam5 dramat-
ically protects mice against cold stress when combined with fasting.
The survival rate of Pgam5 KOmice was signiﬁcantly prolonged com-
pared with that of WTmice (Fig. 1a, right panel), and Pgam5 KOmice
maintained their core body temperature even after a 6-h cold expo-
sure under fasting conditions (Fig. 1b). Interestingly, Pgam5 KOmiceshowed similar vulnerability as WT mice when separately exposed
to either cold stress (Fig. 1c) or fasting (Fig. 1d and e), indicating
that fasting is required for the resistance of Pgam5 KO mice to cold
stress.3.2. The Ablation of Pgam5 Affects Lipid Metabolism Under Fasting and
Cold Stress
As mentioned above, UCP1, as an uncoupler of mitochondrial
respiration, plays crucial roles in adaptive thermogenesis in BAT
(Krauss et al., 2005). Therefore, we next examined the mRNA
expression of Ucp1 in BAT derived from Pgam5 KO mice under
fasting and cold stress. Although the mRNA expression of the Ucp1
gene slightly increased (Figure S2a), the protein expression level
of UCP1 in Pgam5-deﬁcient BAT was similar to that in WT mice
(Figure S2b). mRNA expressions of other thermogenesis-related
genes were also comparable between WT and Pgam5 KO mice
(Figure S2a). Thus, we next focused on lipid metabolism, another
important factor for cold resistance (Townsend and Tseng, 2014).
We found that the triglyceride (TG) level in serum was signiﬁcantly
reduced in Pgam5 KOmice under fasting and cold stress (Fig. 2a, left
panel), although obvious differences were not observed in the
serum FFA level (Fig. 2a, right panel). The serum TG level of Pgam5
KO mice was comparable to that of WT mice upon pre-treatment
with triton WR-1339 (Fig. 2b), which blocks TG removal from plas-
ma by inhibiting lipoprotein lipase (LPL) and is thus often used to
estimate the rate of TG entry into the plasma from the liver
(Goudriaan et al., 2005). Therefore, it is likely that the reduced TG
level in the serum of Pgam5 KO mice is not due to decreased TG re-
lease from the liver but results from enhanced TG uptake and utili-
zation in certain tissues.
It is reported that cold exposure accelerates the plasma clearance of
TG as a result of increased TG uptake and utilization in activated BAT
(Bartelt et al., 2011). Indeed, a signiﬁcant reduction of the BAT weight
ratio was observed in Pgam5 KO mice under the fasting and cold
stress-condition (Fig. 2c and d). Although the difference was not statis-
tically signiﬁcant, the slight decrease of BAT weight ratio was also ob-
served in Pgam5-deﬁcient mice from steady state (Fig. 2d). Actually,
H&E staining of BAT sections revealed that the lipid content of BAT in
Pgam5 KO mice decreased from the basal level (Fig. 2e). Moreover,
the decrease of lipid content in Pgam5-deﬁcient BAT becamemore evi-
dent after fasting and cold stress compared with that in WT mice-
derived BAT (Fig. 2f). By contrast, no signiﬁcant weight loss was ob-
served in other tissues derived from Pgam5 KOmice, such as the ingui-
nal white adipose tissue (iWAT), epididymal white adipose tissue
(eWAT) and liver (Fig. 2g). These results suggest that the ablation of
Pgam5 affects lipid metabolism, most signiﬁcantly in BAT, under fasting
and cold stress.
We next examined the expression amount of lipid metabolism-
related genes focusing on BAT. mRNA expressions of most genes re-
lated to lipid transport, lipolysis, and β-oxidation in BAT of Pgam5
KO mice were comparable to those of WT mice either under basal
or fasting and cold stress-loaded conditions (Figure S3a, b and c).
However, we found that the mRNA expression of Elovl3 was signiﬁ-
cantly enhanced in Pgam5 KO-mice-derived BAT (Fig. 2e). ELOVL3
belongs to the ELOVL family of proteins that act to elongate FFAs
into very long chain fatty acids (VLCFAs) (Westerberg et al., 2006).
Elovl3 expression is reported to be induced after cold exposure, and
Elovl3-deﬁcient mice are only able to survive the cold by shivering
because they lack the elongation activity of FFAs that is needed for
thermogenesis in BAT (Westerberg et al., 2006). Taken all together,
it would be possible that the enhancement of Elovl3 expression in
Pgam5-deﬁcient BAT is one of the causal factors promoting lipid uti-
lization in BAT and conferring subsequent cold resistance to Pgam5
KO mice.
Fig. 1. Pgam5 knockout (KO) mice exhibit a resistance phenotype against cold stress under fasting condition. (a, b) Survival rate and body temperature of WT and Pgam5 KOmice at the
indicated time periods after cold exposure combined with fasting (n = 10). (c) The body temperatures of cold-exposed WT and Pgam5 KO mice were monitored for 60 h under fed
conditions (n = 4). (d, e) The survival rate (d) and body temperatures (e) of WT and Pgam5 KO mice were monitored at the indicated time periods under fasting conditions (WT;
n = 6, KO; n = 5). Data are expressed as the means ± SEM, **p b 0.01, ***p b 0.001; log rank test (a), unpaired Student's t-test (b).
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Fasting and Cold Stress
Because PGAM5 is a mitochondria-resident protein, we next exam-
ined themitochondrial integrity in BAT under fasting and cold stress. Al-
though there were no striking differences inmitochondrialmorphology
under basal conditions (Fig. 3a), electron microscopy analysis revealed
that electron-dense mitochondria appear in Pgam5-deﬁcient BAT
under fasting and cold stress (Fig. 3b and c). Quantitative evaluation of
electron density of each mitochondrion revealed that the number of
electron-dense mitochondria increased in Pgam5-deﬁcient BAT under
fasting and cold stress (Fig. 3d and e).Similar electron-dense mitochondria were reported to be observed
in induced pluripotent stem cells (iPSCs) from Parkinson's disease
patients harboring causative gene mutations in the Parkin gene
(Imaizumi et al., 2012). Because recent studies have suggested that
Parkin deﬁciency results in the accumulation of dysfunctional mito-
chondria due to impaired autophagic degradation of damaged mito-
chondria (Youle and Narendra, 2011), the electron-dense abnormal
mitochondria observed in iPSCs from Parkinson's disease patients
were thought to be dysfunctional. Thus, the electron-dense mitochon-
dria in Pgam5-deﬁcient BAT under fasting and cold stress could also
be interpreted as dysfunctional mitochondria. These results suggest
that Pgam5 deﬁciency results in the failure of preservation of proper
Fig. 2. The ablation of Pgam5 affects lipidmetabolismunder fasting and cold stress. (a) The triglyceride (TG) and free fatty acid (FFA) levels in the serumofWT and Pgam5KOmice under a
6-h cold exposure after 12 h of fasting (n= 21). (b) Estimation of TG release from liver using a lipoprotein lipase (LPL) inhibitor, TritonWR-1339. After 12 h of fasting,WT and Pgam5 KO
mice were intravenously treated with PBS or TritonWR-1339 and subjected to cold stress. After 4 h of cold exposure, the serum TG level wasmeasured (n= 8). (c) Representative gross
image of BAT fromWT and Pgam5KOmice under basal conditions or at 5 h of cold exposure after 12 h of fasting. (d) BATweight ratio ofWT and Pgam5KOmice at 6-h cold exposure after
12-h of fasting. (e and f) RepresentativeH&E staining of BAT sections fromWTand Pgam5KOmice under the indicated conditions. Scale bars, 100 μm. (g) Several-tissueweight ratio ofWT
and Pgam5KOmice at 6 h of cold exposure after 12 h of fasting. (h) Expression of Elovl3, an elongation factor of FFAs in BAT fromWT and Pgam5KOmice under basal conditions or at 6 h of
cold exposure after 12 h of fasting was determined via quantitative RT-PCR (n = 4). Data are expressed as the mean ± SEM, **p b 0.01, ***p b 0.001; unpaired Student's t-test (a and d),
two-way ANOVA/Bonferroni post-test (g). BAT, brown adipose tissue; iWAT, inguinal white adipose tissue; eWAT, epididymal white adipose tissue.
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conditions that may impose metabolic challenges on mitochondria.
3.4. FGF21 Expression is Enhanced in Pgam5-deﬁcient BAT Under Fasting
and Cold Stress
Although the proper mitochondrial integrity was reduced in BAT, an
important tissue for adaptive thermogenesis (Fig. 3b–e), Pgam5 KO
mice were resistant against fasting and cold stress (Fig. 1a and b). Thus,
we hypothesized that some compensatory mechanisms may operate in
Pgam5-deﬁcient BAT in order to maintain the whole-body homeostasis.Fibroblast growth factor 21 (FGF21) is known to be induced in re-
sponse to several stresses, including fasting and cold stress, andultimately
confers resistance to these metabolic stresses by promoting fuel delivery
(Badman et al., 2009; Potthoff et al., 2009) and adaptive thermogenesis
(Fisher et al., 2012; Hondares et al., 2010). Moreover, several recent re-
ports suggested that dysfunctional mitochondria induce FGF21 (Dogan
et al., 2014; Keipert et al., 2014; Kim et al., 2013a,b). Strikingly, we
found that mRNA expression of Fgf21was greatly enhanced in Pgam5-
deﬁcient BAT (Fig. 4a). Because it is known that FGF21 is released from
various tissues, including BAT, liver and muscle, depending on the type
of stress (Owen et al., 2015), we next examined the tissue speciﬁcity
Fig. 3. Pgam5-deﬁcient BAT exhibits altered mitochondrial integrity under fasting and cold stress. (a, b and c) Representative electron micrographs of mitochondria in BAT derived from
WT and Pgam5 KOmice under basal conditions (a) or at 6 h of cold exposure after 12 h of fasting (b and c). Images in (b) and (c) were obtained from different experiments. Scale bars,
1.0 μm(a), 2.0 μm(b) and 500 nm(c).White arrowheads indicate electron-densemitochondria. (d and e) Thequantitative evaluation of electron density of eachmitochondrion in (b). The
mean gray scale value was measured using Image J for each mitochondrion in BAT derived fromWT and Pgam5 KO mice. Approximately 150 mitochondria from 8–9 images for each
mouse and approximately 450 mitochondria in total for each genotype were analyzed (n = 3). Data are means ± SD, ***p b 0.001; unpaired Student's t-test (d). Mitochondria whose
mean gray scale value was greater than the Average + 3SD of WT mice were designated as electron-dense mitochondria, and their relative frequency was calculated (e).
87S. Sekine et al. / EBioMedicine 5 (2016) 82–92and stress dependence of the enhancement of Fgf21 in Pgam5-deﬁcient
BAT. In addition to BAT, the expression level of Fgf21mRNA was slightly
but signiﬁcantly enhanced in Pgam5 KO mice-derived iWAT, but not in
other tissues such as liver and muscle (Fig. 4b).
Moreover, the enhancement of Fgf21 in Pgam5-deﬁcient BAT was
only observed under fasting and cold together but not under fasting or
cold stress alone (Fig. 4c), which correlates with the phenotypes for
body temperature and survival (Fig. 1a-e). Immunoblot analysis using
BAT lysates derived from mice that were treated with fasting and cold
stress revealed that the enhancement of FGF21 also occurs at the pro-
tein level in Pgam5 KOmice (Fig. 4d). These results suggest that the ab-
lation of Pgam5 promotes Fgf21 gene expression in a tissue- and stress-
speciﬁc manner.
3.5. The Enhancement of FGF21 in Pgam5-deﬁcient BAT is Induced by the
Phospho-eif2α-ATF4 Pathway
We next attempted to identify the signaling pathway that regu-
lates FGF21 induction in Pgam5-deﬁcient BAT under fasting andcold stress. The phosphorylation of eif2α is induced by several
stresses and subsequently triggers several gene expression programs
by enhancing the translation of transcription factors, including ATF4,
which is called the integrated stress response (ISR) (Baird and Wek,
2012). In addition, it has recently been reported that mitochondrial
dysfunction due to the deﬁciency of the autophagy-dependent clear-
ance of damaged mitochondria can also activate the phospho-eif2α-
ATF4 pathway, which results in FGF21 induction (Kim et al., 2013b).
Interestingly, the phosphorylation of eif2α in Pgam5-deﬁcient BAT is
markedly enhanced under fasting and cold stress compared with
that observed in WT mice (Fig. 4d). Moreover, the pre-treatment
with ISRIB, a recently identiﬁed phospho-eif2α-ATF4 pathway-
selective inhibitor (Sekine et al., 2015; Sidrauski et al., 2013), almost
completely suppressed the enhancement of Fgf21 induction in
Pgam5-deﬁcient BAT under fasting and cold stress (Fig. 4e). These
results suggest that the ablation of Pgam5 fails to maintain proper
mitochondrial integrity under fasting and cold stress, which might
ultimately lead to phospho-eif2α-ATF4-pathway-dependent FGF21
induction.
Fig. 4. Phospho-eif2α-ATF4-pathway-mediated FGF21 induction is enhanced in Pgam5 KO-mice-derived brown adipose tissue under fasting and cold stress. (a and b) Fgf21 gene
expression in the indicated tissues from WT and Pgam5 KO mice under basal conditions or at 6 h of cold exposure after 12 h of fasting according to quantitative RT-PCR (n = 4).
(c) Fgf21 gene expression in BAT derived fromWT and Pgam5 KO mice under basal conditions, 18 h after fasting only (fast), 6 h after cold stress only (cold), and 6 h of cold exposure
after 12 h of fasting (fast + cold) was determined using quantitative RT-PCR (n = 4). (d) Representative immunoblots for the indicated proteins derived from WT and Pgam5 KO
mice under basal conditions or at 3 h of cold exposure after 12 h of fasting. (e) After fasting for 12 h, WT and Pgam5 KO mice were treated with 2.5 mg/kg body weight ISRIB or mock
i.p. and subsequently exposed to cold stress. After 5 h, Fgf21 gene expression in BAT was determined using quantitative RT-PCR (WT; n = 4 for each, Pgam5 KO; mock n = 3, ISRIB
n = 4). Data are expressed as the mean ± SEM, *p b 0.05, **p b 0.01, ***p b 0.001; two-way ANOVA/Bonferroni post-test (a, b, c, and e). BAT, brown adipose tissue; iWAT, inguinal
white adipose tissue; CNS, central nervous systems.
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induced Obesity Model
Finally, because cold sensitivity and resistance phenotypes in mice
are well correlated with obese and lean phenotypes, respectively (Lin
and Li, 2004), we examined the impact of metabolic stress by feeding
Pgam5 KO mice a high-fat diet (HFD). The weight gain in HFD-fed
Pgam5 KO mice was dramatically suppressed compared with that in
WT mice (Fig. 5a and b). Although there were no obvious differences
in fat mass or liver mass between WT mice and Pgam5 KO mice under
chow diet (CD)-fed conditions (Fig. 5c), a signiﬁcant reduction of thefat mass and liver mass in HFD-fed Pgam5 KOmice was observed com-
pared withWTmice (Fig. 5d and e). H&E staining of BAT and iWAT also
supports the suppression of lipid accumulation in HFD-fed Pgam5 KO
mice (Fig. 5f).
In addition to decreased fat mass, an intraperitoneal glucose toler-
ance test (GTT) and insulin tolerance test (ITT) revealed that Pgam5
KO mice had enhanced glucose tolerance and insulin sensitivity com-
pared with WT mice (Fig. 5g and h). Moreover, although whole-body
energy expenditure in Pgam5 KO mice was comparable to that of WT
mice under CD-fed conditions (Fig. 5i), energy expenditure was signi-
ﬁcantly enhanced compared with that of WT mice under HFD-fed
Fig. 5. Pgam5 KOmice are resistant to high-fat-diet-induced obesity. (a) Representative picture of 16-week-oldmice thatwere fed a high-fat diet (HFD) for 11 weeks. (b) Bodyweights of
WT and Pgam5KOmice that were fed a HFD (n=5). (c and d) Tissueweight ratio-normalized bodyweights ofWT and Pgam5KOmice under CD (n=4) (c) orHFD for 12weeks (n=8)
(d). (e) Representative gross image of BAT and liver fromWT and Pgam5 KOmice that were fed a HFD for 12weeks. (f) Representative H&E staining of the indicated fat sections fromWT
and Pgam5 KOmice that were fed a HFD for 7 weeks. Scale bars, 100 μm. (g and h) GTT (g) inWT and Pgam5 KOmice that were fed a HFD for 12 weeks (n= 5) and ITT (h) in WT and
Pgam5KOmice thatwere fed a HFD for 8weeks (n=6). (i and j) Oxygen consumption ofmale 9-week-oldWT andPgam5KOmice under CD (n=4) (i) and 16-week-oldWT and Pgam5
KOmice that were fed a HFD for 12weeks (n= 4) (j). Data are expressed as themean± SEM, *p b 0.05, **p b 0.01, ***p b 0.001; unpaired Student's t-test (c, d, i and j), two-way ANOVA/
Bonferroni post-test (b, g, and h). BAT, brown adipose tissue; iWAT, inguinal white adipose tissue; eWAT, epididymal white adipose tissue.
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protects mice from HFD-induced obesity.
4. Discussion
In this report, we uncovered two metabolic-stress-related phe-
notypes of Pgam5KOmice. In our analysis of the cold-resistance pheno-
types of Pgam5 KOmice under fasting condition, we focused especially
on BAT, a center of adaptive thermogenesis. Under cold exposure, it is
known that BAT is a major tissue that takes up TGs from the blood
stream (Bartelt et al., 2011). In BAT, TGs that were transported fromthe blood stream and those that were stored in lipid droplets were de-
graded to release FFAs via lipolysis in response to cold (Townsend and
Tseng, 2014). The released FFAs not only become fuel for β-oxidation
but also promote adaptive thermogenesis through activating UCP1-
mediated thermogenesis (Fedorenko et al., 2012). Thus, the enhanced
lipid utilization in BAT is critical for cold resistance. Of note, several
signs of enhanced lipid metabolism were observed in Pgam5 KO mice
after fasting and cold stress: serum TGs decreased in Pgam5 KO mice
(Fig. 2a), lipid droplets were signiﬁcantly smaller in Pgam5-deﬁcient
BAT (Fig. 2f), and the expression level of lipid elongation factor, Elovl3
was enhanced in Pgam5-deﬁcient BAT (Fig. 2h). These observations
Fig. 6. Summary of phenotypes of Pgam5 KO mice under the fasting and cold stress. See detailed explanation in Discussion.
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uptake and utilization in BAT, which ultimately confers the cold resis-
tance to mice (Fig. 6). Because the decrease of lipid content in Pgam5-
deﬁcient BAT was striking (Fig. 2e and f), uncovering the precise mech-
anismsbywhichmitochondria-resident PGAM5 regulates the activity of
BAT is expected in the future study. Interestingly, recent report suggests
that adrenergic stimulation promotes rapid mitochondrial ﬁssion in
brown adipocytes,which ultimately results in promoting energy expen-
diture (Wikstrom et al., 2014). Moreover, it has been reported that the
ablation PGAM5 promotes rapid mitochondrial fragmentation in some
cells under several stress conditions (Wang et al., 2012; Moriwaki
et al., 2016). Thus, it would be possible that PGAM5 in BAT might be
also involved in the regulation of mitochondrial dynamics. Alternative-
ly, considering that the lipidmetabolism in BAT is known to be activated
by sympathetic nervous system, it would be possible that the enhanced
lipidmetabolism observed in Pgam5-deﬁcient BAT is induced by the in-
creased sympathetic neuronal input. For further understanding of the
roles of PGAM5 in lipid metabolism in BAT, it is required to determine
in which tissues PGAM5 exert its roles, i.e. in BAT itself, central nervous
system, or even other tissues.
Another critical alteration in Pgam5-deﬁcient BAT under fasting and
cold stress is the enhancement of FGF21 (Fig. 4a and d). Because thepre-
treatment of ISRIB almost completely blocked the enhancement of Fgf21
expression in Pgam5-deﬁcient BAT (Fig. 4e), phospho-eif2α-ATF4 path-
waymay be involved in the enhanced FGF21 induction. From the previ-
ous analysis of Fgf21 KOmice, it is known that FGF21 contributes to cold
resistance (Fisher et al., 2012). In addition, FGF21 has been shown topromote lipid metabolism (Owen et al., 2015). Unexpectedly, however,
the pre-treatment of ISRIB did not suppress the enhanced lipid metabo-
lism observed in Pgam5 KO mice (Figure S4a and b). Therefore, FGF21
induction may not be causal for the enhancement of lipid metabolism
at least in Pgam5 KO mice (Fig. 6).
Several recent reports suggested that dysfunctional mitochondria
activate the phospho-eif2α-ATF4 pathway, which eventually leads to
FGF21 induction (Dogan et al., 2014; Keipert et al., 2014; Kim et al.,
2013a,b). Enhanced eif2α phosphorylation (Fig. 4d) and electron-
dense abnormal mitochondria (Fig. 3b-e) were observed in Pgam5-
deﬁcient BAT after fasting and cold stress. From these observations,
we nowhypothesize that the appearance of dysfunctionalmitochondria
in Pgam5-deﬁcient BAT under fasting and cold stress might activate the
phospho-eif2α-ATF4 pathway, which triggers the FGF21 induction (Fig.
6). Uncovering the precise molecular mechanisms by which PGAM5
protects proper mitochondrial integrity under fasting and cold stress
is one of the most tempting future directions. It would be possible that
PGAM5 in BAT itself protects proper mitochondrial integrity from
metabolic perturbations. Alternatively, it could be speculated that
exhausted mitochondria intolerable to metabolic challenges caused by
the enhanced lipid metabolism may give rise to dysfunctional mito-
chondria in Pgam5-deﬁcient BAT.
The resistance to HFD-induced obesity was another drastic phe-
notype of Pgam5 KO mice (Fig. 5a–j). It has been reported that the ad-
ministration of FGF21 or its analogs induces weight loss through
increased energy expenditure (Coskun et al., 2008; Gaich et al., 2013;
Kharitonenkov et al., 2005). Because FGF21 induction was enhanced in
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examined the possibility that its enhancement also contributes to the
lean phenotype of Pgam5 KOmice under HFD-fed conditions. However,
serum FGF21 concentration was even reduced in Pgam5 KOmice under
HFD-fed conditions (Figure S5). Several previous studies also reported
that the serum FGF21 level is rather increased in obese animals com-
pared with lean animals (Zhang et al., 2008), raising the possibility
that obesity is an FGF21-resistance condition (Fisher et al., 2010).
Thus, the above results in Pgam5 KO mice might reﬂect these previous
observations. The identiﬁcation of the factors that are responsible for
the resistance of Pgam5 KO mice to HFD-induced obesity is expected
in future studies. Several clinical studies suggest the inverse correlation
between the BAT activity and body fatness (Lee et al., 2014). In this as-
pect, it is noteworthy that the lipid utilization might be activated in
Pgam5-deﬁcient BAT under stressed conditions or even from basal
state (Fig. 2f and e). Moreover, very recently, it has been reported that
PGAM5 KO mice show slight decrease of body weight from basal state
(Moriwaki et al., 2016). The elucidation of themechanisms of enhanced
lipidmetabolism in Pgam5-deﬁcient BATmay not only uncover the rea-
sons why Pgam5 KO mice show such a drastic lean phenotype but also
provide some clinical clues to the therapeutic targets for human obesity
and related metabolic disorders.
In this report, we found that mitochondria-resident stress respon-
sive protein PGAM5 acts as a metabolic regulator in vivo. We hope
that our study will provide a key to uncover more detailed functions
of PGAM5 as a metabolic regulator and will shed new light on mito-
chondrial stress-responsive molecules as potential therapeutic targets
for metabolic disorders.
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